Showing results (11-20 of 67) with videos related to
Sort By:
Pageof 7
Basic & Clinical Pharmacology & Toxicology|September 13, 2019
Modelling gastric emptying: A pharmacokinetic model simultaneously describing distribution of losartan and its active metabolite EXP-3174Eleni Karatza, Vangelis KaralisThe Journal of Pharmacy and Pharmacology|November 2, 2013
On the statistical model of the two-stage designs in bioequivalence assessmentVangelis Karalis, Panos MacherasXenobiotica; the Fate of Foreign Compounds in Biological Systems|April 10, 2018
On the population pharmacokinetics and the enterohepatic recirculation of total ezetimibeKonstantina Soulele, Vangelis KaralisJournal of Pharmaceutical Sciences|November 20, 2012
Exploring the relationships between scaled bioequivalence limits and within-subject variabilityMira Symillides, Vangelis Karalis, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 28, 2011
On the leveling-off properties of the new bioequivalence limits for highly variable drugs of the EMA guidelineVangelis Karalis, Mira Symillides, Panos MacherasPharmaceutical Research|November 24, 2004
Novel scaled average bioequivalence limits based on GMR and variability considerationsVangelis Karalis, Mira Symillides, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2005
Geometric mean ratio-dependent scaled bioequivalence limits with leveling-off propertiesVangelis Karalis, Panos Macheras, Mira SymillidesXenobiotica; the Fate of Foreign Compounds in Biological Systems|April 13, 2021
Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimensEleni Karatza, George Ismailos, Vangelis KaralisExpert Opinion on Drug Metabolism & Toxicology|December 2, 2010
Novel methods to assess bioequivalenceVangelis Karalis, Mira Symillides, Panos MacherasEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 16, 2009
Comparison of the reference scaled bioequivalence semi-replicate method with other approaches: focus on human exposure to drugsVangelis Karalis, Mira Symillides, Panos MacherasPageof 7